Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$94.21
+4.9%
$96.26
$77.10
$163.71
$5.40B0.781.21 million shs688,079 shs
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$95.80
+4.6%
$117.55
$73.92
$225.00
$2.84B1.221.66 million shs559,798 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$264.67
+5.3%
$246.20
$184.80
$310.00
$10.32B0.4481,348 shs604,846 shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€22.52
-1.4%
€24.34
€17.12
€28.00
€6.85B0.55407,842 shs336,900 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
+4.87%+4.77%-1.88%-2.10%-27.53%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+4.40%+9.27%-27.35%-33.12%-48.86%
Penumbra, Inc. stock logo
PEN
Penumbra
+4.90%+4.62%+13.14%-1.51%+35.71%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
-1.18%-0.13%-11.41%+1.26%+17.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Glaukos Corporation stock logo
GKOS
Glaukos
4.7266 of 5 stars
4.44.00.04.42.81.70.6
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.9386 of 5 stars
4.34.00.04.83.91.71.9
Penumbra, Inc. stock logo
PEN
Penumbra
4.8117 of 5 stars
3.55.00.03.72.92.51.9
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.1495 of 5 stars
0.04.01.70.02.30.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Corporation stock logo
GKOS
Glaukos
2.79
Moderate Buy$127.4235.25% Upside
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.54
Moderate Buy$165.6272.88% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.94
Moderate Buy$300.4713.52% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.83
Moderate BuyN/AN/A

Current Analyst Ratings Breakdown

Latest INSP, PEN, STVN, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/15/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$116.00 ➝ $97.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$270.00 ➝ $150.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$174.00 ➝ $101.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$270.00 ➝ $230.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$215.00 ➝ $180.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$233.00 ➝ $150.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$190.00 ➝ $125.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ Hold$175.00 ➝ $140.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$195.00 ➝ $110.00
8/5/2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Sector Weight
(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Corporation stock logo
GKOS
Glaukos
$383.48M14.09N/AN/A$13.34 per share7.06
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$802.80M3.53$1.71 per share56.18$22.92 per share4.18
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.64$2.89 per share91.71$33.18 per share7.98
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.15B5.96€0.75 per share29.97€5.24 per share4.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%11/3/2025 (Estimated)
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$53.51M$1.7355.3729.752.996.17%10.38%8.93%11/3/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7670.3952.832.3811.54%11.55%8.76%10/29/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5441.7038.832.1311.73%10.34%6.21%N/A

Latest INSP, PEN, STVN, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$0.22$0.45+$0.23-$0.12$214.50 million$217.09 million
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 million
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
5.51
4.69
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.14
4.84
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.25
1.79
1.22

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A

Insider Ownership

CompanyInsider Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
5.80%
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
4.10%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.35 million54.02 millionOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,24629.57 million28.36 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.36 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 million300.72 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Glaukos stock logo

Glaukos NYSE:GKOS

$94.21 +4.42 (+4.92%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$94.17 -0.04 (-0.04%)
As of 08/22/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$95.80 +4.18 (+4.56%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$96.01 +0.21 (+0.22%)
As of 08/22/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Penumbra stock logo

Penumbra NYSE:PEN

$264.67 +13.30 (+5.29%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$264.74 +0.07 (+0.03%)
As of 08/22/2025 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€22.52 -0.33 (-1.44%)
As of 08/22/2025 03:58 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.